This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Navon-Venezia, S.
Right arrow Articles by Carmeli, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Navon-Venezia, S.
Right arrow Articles by Carmeli, Y.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2003, p. 155-158, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.155-158.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Occurrence and Phenotypic Characteristics of Extended-Spectrum ß-Lactamases among Members of the Family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and Evaluation of Diagnostic Tests

Shiri Navon-Venezia,1 Orly Hammer-Munz,1 David Schwartz,2 Dan Turner,3 Boris Kuzmenko,1 and Yehuda Carmeli1,3*

Laboratories for Molecular Epidemiology,1 Microbiology,2 Division of Infectious Diseases, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel3

Received 7 August 2002/ Returned for modification 1 October 2002/ Accepted 20 October 2002

We assessed the prevalence and phenotypic characteristics of extended-spectrum ß-lactamase (ESBL) producers among cefuroxime-resistant (CXM-R) (MIC >= 32 µg/ml) members of the family Enterobacteriaceae in our institution. The 438 CXM-R clinical isolates obtained from nonurine sources among inpatients were screened. ESBL production was confirmed by disk diffusion assay using cefpodoxime (CPD), cefotaxime (CTX), and ceftazidime (CTZ) with and without clavulanate (CLAV). A difference of >=5 mm in the size of the zone of inhibition in the presence of CLAV for at least one of the agents was considered representative of the ESBL phenotype: 186 isolates (42.5%) were confirmed as ESBL producers. The isolates tested and the rates of ESBL producers were as follows: Klebsiella spp. (n = 81), 79%; Proteus spp. (n = 58), 62%; Escherichia coli (n = 64), 53%; Enterobacter spp. (n = 69), 42%; Serratia spp. (n = 70), 14%; Citrobacter spp. (n = 25), 24%; Providencia spp. (n = 21), 24%; Morganella spp. (n = 41), 5%; and Kluyvera (n = 3), 0%. The overall sensitivity of isolated ESBL confirmatory tests was 79% for CPD-CLAV, 66% for CTZ-CLAV, and 91% for CTX-CLAV. Sensitivities of CTZ-CLAV confirmatory tests for Klebsiella spp., Proteus spp., E. coli, and Enterobacter spp. were 84, 22, 76, and 62%, respectively, and those for CTX-CLAV were 95, 97, 94, and 83%, respectively. They were 90% for CPD-CLAV and CTZ-CLAV, 95% for CPD-CLAV and CTX-CLAV, and 100% for CTZ-CLAV and CTX-CLAV. ESBL production was highly prevalent among Enterobacteriaceae. Using resistance to CXM as an ESBL screening criterion is a suitable option in high-incidence areas where Klebsiella spp. are not the dominant ESBL producers. This screening criterion may simplify the screening test and improve its sensitivity, although at the price of testing more isolates. The CTX-CLAV combination confirmed ESBL producers better than the CTZ-CLAV combination, with sensitivity varying between species. Combined CTZ-CLAV and CTX-CLAV testing detected all these strains; CPD-CLAV provided no additional benefit.

* Corresponding author. Mailing address: Divisions of Infectious Diseases and Epidemiology, Tel-Aviv Sourasky Medical Center, 6 Weizman St., Tel-Aviv 64239, Israel. Phone: 972-3-692 5644. Fax: 972-3-6974996. E-mail: ycarmeli{at}caregroup.harvard.edu.

Journal of Clinical Microbiology, January 2003, p. 155-158, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.155-158.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Leavitt, A., Chmelnitsky, I., Colodner, R., Ofek, I., Carmeli, Y., Navon-Venezia, S. (2009). Ertapenem Resistance among Extended-Spectrum-{beta}-Lactamase-Producing Klebsiella pneumoniae Isolates. J. Clin. Microbiol. 47: 969-974 [Abstract] [Full Text]  
  • Park, Y.-J., Yu, J. K., Lee, S., Park, J.-J., Oh, E.-J. (2007). Evaluation of Phoenix Automated Microbiology System for Detecting Extended-Spectrum {beta}-Lactamases among Chromosomal AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii, and Serratia marcescens. Annals of Clinical & Laboratory Science 37: 75-78 [Abstract] [Full Text]  
  • Chmelnitsky, I., Carmeli, Y., Leavitt, A., Schwaber, M. J., Navon-Venezia, S. (2005). CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum Beta-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49: 4745-4750 [Abstract] [Full Text]  
  • Paterson, D. L., Bonomo, R. A. (2005). Extended-Spectrum {beta}-Lactamases: a Clinical Update. Clin. Microbiol. Rev. 18: 657-686 [Abstract] [Full Text]  
  • Schwaber, M. J., Navon-Venezia, S., Schwartz, D., Carmeli, Y. (2005). High Levels of Antimicrobial Coresistance among Extended-Spectrum-{beta}-Lactamase-Producing Enterobacteriaceae. Antimicrob. Agents Chemother. 49: 2137-2139 [Abstract] [Full Text]  
  • Schlesinger, J., Navon-Venezia, S., Chmelnitsky, I., Hammer-Munz, O., Leavitt, A., Gold, H. S., Schwaber, M. J., Carmeli, Y. (2005). Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel. Antimicrob. Agents Chemother. 49: 1150-1156 [Abstract] [Full Text]  
  • Jonathan, N. (2005). Screening for Extended-Spectrum Beta-Lactamase-Producing Pathogenic Enterobacteria in District General Hospitals. J. Clin. Microbiol. 43: 1488-1490 [Full Text]  
  • Navon-Venezia, S., Leavitt, A., Ben-Ami, R., Aharoni, Y., Schwaber, M. J., Schwartz, D., Carmeli, Y. (2005). Evaluation of an Accelerated Protocol for Detection of Extended-Spectrum {beta}-Lactamase-Producing Gram-Negative Bacilli from Positive Blood Cultures. J. Clin. Microbiol. 43: 439-441 [Abstract] [Full Text]  
  • Sompolinsky, D., Nitzan, Y., Tetry, S., Wolk, M., Vulikh, I., Kerrn, M. B., Sandvang, D., Hershkovits, G., Katcoff, D. J. (2005). Integron-mediated ESBL resistance in rare serotypes of Escherichia coli causing infections in an elderly population of Israel. J Antimicrob Chemother 55: 119-122 [Abstract] [Full Text]  
  • Literacka, E., Empel, J., Baraniak, A., Sadowy, E., Hryniewicz, W., Gniadkowski, M. (2004). Four Variants of the Citrobacter freundii AmpC-Type Cephalosporinases, Including Novel Enzymes CMY-14 and CMY-15, in a Proteus mirabilis Clone Widespread in Poland. Antimicrob. Agents Chemother. 48: 4136-4143 [Abstract] [Full Text]  
  • Shannon, K. P., French, G. L. (2004). Increasing resistance to antimicrobial agents of Gram-negative organisms isolated at a London teaching hospital, 1995-2000. J Antimicrob Chemother 53: 818-825 [Abstract] [Full Text]  
  • Tumbarello, M., Citton, R., Spanu, T., Sanguinetti, M., Romano, L., Fadda, G., Cauda, R. (2004). ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother 53: 277-282 [Abstract] [Full Text]  
  • De Gheldre, Y., Avesani, V., Berhin, C., Delmee, M., Glupczynski, Y. (2003). Evaluation of Oxoid combination discs for detection of extended-spectrum {beta}-lactamases. J Antimicrob Chemother 52: 591-597 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»